Rankings
▼
Calendar
ANNX Q4 2018 Earnings — Annexon, Inc. Revenue & Financial Results | Market Cap Arena
ANNX
Annexon, Inc.
$706M
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$5M
Net Income
-$5M
EPS (Diluted)
$-11.01
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$99,000
Balance Sheet
Total Assets
$48M
Total Liabilities
$10M
Stockholders' Equity
$38M
Cash & Equivalents
$44M
← FY 2018
All Quarters
Q1 2019 →